# FDA Inspection 808119 - Boehringer Ingelheim Pharma GmbH & Co. KG - November 12, 2012

Source: https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/952b84e6-8762-4fed-9763-68c3266907f3
Source feed: FDA_Inspections

> FDA Inspection 808119 for Boehringer Ingelheim Pharma GmbH & Co. KG on November 12, 2012. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 808119
- Company Name: Boehringer Ingelheim Pharma GmbH & Co. KG
- Inspection Date: 2012-11-12
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1208521 - 2021-10-07](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/9d43c9ec-b673-4acd-9149-001abff90db2)
- [FDA Inspection 1053519 - 2018-05-04](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/256e5980-df7b-4049-9703-ac50c6fbc5de)
- [FDA Inspection 1053519 - 2018-05-04](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/3b1157b7-eb68-4ae7-80b6-a033ffb491eb)
- [FDA Inspection 962108 - 2016-03-08](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/f1d99f01-f80f-4e2f-9332-40876897d636)
- [FDA Inspection 921540 - 2015-01-23](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharma-gmbh-co-kg/3695817e-3e64-4348-a694-1b0f21566aad)

Company: https://www.keypedia.com/companies/boehringer-ingelheim-pharma-gmbh-co-kg/bcb705bf-98ed-451f-a79d-b6223d2ed263

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c